New estimates up dementia rates in mid-income countries

May 24, 2012
New estimates up dementia rates in mid-Income countries
Use of 10/66 dementia diagnosis criteria results in an increase in the estimated incidence of dementia in middle-income countries, according to a study published online May 23 in The Lancet.

(HealthDay) -- Use of 10/66 dementia diagnosis criteria (10/66) results in an increase in the estimated incidence of dementia in middle-income countries, according to a study published online May 23 in The Lancet.

To investigate the incidence of dementia, Martin Prince, M.D., from King's College London, and colleagues conducted a population-based cohort study of 12,887 individuals aged 65 years or older residing in urban sites in Cuba, the Dominican Republic, and Venezuela, and in rural and urban sites in Peru, Mexico, and China. Three to five years after cohort inception, incident dementia was ascertained using 10/66 and , Fourth Edition (DSM-IV) criteria.

Of the participants interviewed at baseline, the researchers found that 11,718 were free of dementia, 69 percent of whom were reinterviewed. During the resulting 34,718 person-years of follow-up, the incidence for 10/66 dementia was 1.4 to 2.7 times higher than the incidence for DSM-IV dementia, ranging from 18.2 to 30.4 per 1,000 person-years. Compared with those who were dementia-free, the risk of mortality was 1.56 to 5.69 times higher for individuals with dementia at baseline. Based on 10/66 , increased incidence of dementia correlated with increased age (hazard ratio [HR], 1.67), and decreased incidence of dementia correlated with male sex (HR, 0.72) and higher education (HR, 0.89); no significant correlation was observed with occupational attainment (HR, 1.04; 95 percent confidence interval, 0.95 to 1.13).

"Our results provide supportive evidence for the cognitive reserve hypothesis, showing that in middle-income countries as in high-income countries, education, literacy, , and motor sequencing confer substantial protection against the onset of dementia," the authors write.

The 10/66 Research Group works closely with Alzheimer's Disease International, which is partially funded by the pharmaceutical industry.

Explore further: Mild cognitive impairment is associated with disability and neuropsychiatric symptoms

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Mild cognitive impairment is associated with disability and neuropsychiatric symptoms

February 7, 2012
In low- and middle-income countries, mild cognitive impairment—an intermediate state between normal signs of cognitive aging, such as becoming increasingly forgetful, and dementia, which may or may not progress—is ...

Keeping up your overall health may keep dementia away

July 13, 2011
Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision and hearing, may lower a person's risk for developing dementia, according to a new study published in the July ...

Demographic, clinical factors appear associated with survival in patients with Parkinson's disease

January 2, 2012
Demographics and clinical factors appear to be associated with survival in patients with Parkinson disease (PD), and the presence of dementia is associated with a significant increase in mortality, according to a report in ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.